Bacterial Conjunctivitis Drug Market Competitive Analysis By Cost Estimation, Production, Segments, Key Players Growth Potentials, Industry Size, Share, Global Trends, Business Opportunities and Regional Industry Overview 2019 – 2026
Bacterial conjunctivitis is inflammation in the eye that include swelling, watery eyes, and redness of the eye. Staphylococci, Haemophilus, Chlamydia trachomatis, and streptococci are common bacteria that cause conjunctivitis. The increasing cases of bacterial conjunctivitis are fueling the demand for effective medicine to treat bacterial conjunctivitis.
To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/714
By Disease Type
- Acute Bacterial Conjunctivitis
- Chronic Bacterial Conjunctivitis
By Treatment Type
By Route of Administration
By End User
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/714
Rising incidences of bacterial conjunctivitis and availability of generic drugs are fostering the market growth
The spread of ophthalmic bacterial infection has raised the demand for antibacterial drugs for its treatment. According to the National Center for Biotechnology Information (NCBI) 2013 report, in the U.S., there were around 6 million people affected by conjunctivitis. There are certain drugs in the market that are patented and their patents are about to expire, which is expected to increase the market growth for generic drugs. Moxeza, vigamox, besivance, and zymaxid are some of the most successful patented drugs about to expire. After patent expiry, these drugs lose their exclusivity, which leads to an increase in the use of generic drugs. Therefore, the development of multi-drug resistant variants is projected to fuel the growth of the bacterial conjunctivitis drug market.
Increasing occurrence of bacterial conjunctivitis is fueling the demand for safe and efficient drugs, which leads to the development of new drugs, such as vancomycin ophthalmic ointment, that are in the clinical trial pipeline and few are pending for approval, which is also expected to propel the market growth. Moreover, the rising adoption of herbal formulation based drugs will further favor market growth.
On the basis of geography, the bacterial conjunctivitis drug market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the bacterial conjunctivitis drugs market owing to the presence of advanced healthcare facilities and favorable reimbursement policies. At the same time, Europe is the second-largest region followed by the Asia Pacific. The Asia Pacific is expected to witness moderate growth over the forecast period due to rising awareness regarding the disease among public and high per capita income.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/bacterial-conjunctivitis-drug-market-714
Some of the key players contributing to the bacterial conjunctivitis drug market growth are, Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., and Allergan Plc. For increasing market share, companies adopt various strategies such as mergers and acquisitions. For instance, in 2015, Shire acquired Foresight Biotherapeutics to increase its ophthalmic product pipeline.
Table of Content
Global Bacterial Conjunctivitis Drug Market Research Report
Section 1: Global Bacterial Conjunctivitis Drug Industry Overview
Section 2: Global Economic Impact on Bacterial Conjunctivitis Drug Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Bacterial Conjunctivitis Drug Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Bacterial Conjunctivitis Drug Market Forecast
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/714About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire